Literature DB >> 6235983

Dyggve-Melchior-Clausen syndrome: normal degradation of proteodermatan sulfate, proteokeratan sulfate and heparan sulfate.

M Beck, R Lücke, H Kresse.   

Abstract

It had been suggested that Dyggve-Melchior-Clausen syndrome may be due to the deficiency of a specific sulfatase and/or a protease involved in proteoglycan degradation. The ability of Dyggve-Melchior-Clausen fibroblasts to endocytose and degrade 3H-leucine- and 35S-sulfate-labelled proteodermatan sulfate and 35S-sulfate-labelled proteokeratan sulfate, respectively, was therefore investigated. The turnover of cell-associated 35S-sulfate-labelled heparan sulfate was also followed. In all these experiments Dyggve-Melchior-Clausen fibroblasts behaved normally.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6235983     DOI: 10.1016/0009-8981(84)90161-x

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  3 in total

1.  Dyggve-Melchior-Clausen syndrome.

Authors:  P Beighton
Journal:  J Med Genet       Date:  1990-08       Impact factor: 6.318

2.  Homozygosity mapping of a Dyggve-Melchior-Clausen syndrome gene to chromosome 18q21.1.

Authors:  C Thauvin-Robinet; V El Ghouzzi; W Chemaitilly; N Dagoneau; O Boute; G Viot; A Mégarbané; A Sefiani; A Munnich; M Le Merrer; V Cormier-Daire
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

3.  Dyggve-Melchior-Clausen syndrome: clinical, genetic, and radiological study of 15 Egyptian patients from nine unrelated families.

Authors:  Mona S Aglan; Samia A Temtamy; Ekram Fateen; Adel M Ashour; Khamis Eldeeb; Gamal A Hosny
Journal:  J Child Orthop       Date:  2009-10-09       Impact factor: 1.548

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.